<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Steinlein, P.</title>
    <link>http://repub.eur.nl/res/aut/6801/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Differential regulation of Foxo3a target genes in erythropoiesis (Article)</title>
      <link>http://repub.eur.nl/res/pub/35952/</link>
      <pubDate>2007-05-01T00:00:00Z</pubDate>
      <description>The cooperation of stem cell factor (SCF) and erythropoietin (Epo) is required to induce renewal divisions in erythroid progenitors, whereas differentiation to mature erythrocytes requires the presence of Epo only. Epo and SCF activate common signaling pathways such as the activation of protein kinase B (PKB) and the subsequent phosphorylation and inactivation of Foxo3a. In contrast, only Epo activates Stat5. Both Foxo3a and Stat5 promote erythroid differentiation. To understand the interplay of SCF and Epo in maintaining the balance between renewal and differentiation during erythroid development, we investigated differential Foxo3a target regulation by Epo and SCF. Expression profiling revealed that a subset of Foxo3a targets was not inhibited but was activated by Epo. One of these genes was Cited2. Transcriptional control of Epo/Foxo3a-induced Cited2 was studied and compared with that of the Epo-repressed Foxo3a target Btg1. We show that in response to Epo, the allegedly growth-inhibitory factor Foxo3a associates with the allegedly growth-stimulatory factor Stat5 in the nucleus, which is required for Epo-induced Cited2 expression. In contrast, Btg1 expression is controlled by the cooperation of Foxo3a with cyclic AMP- and Jun kinase-dependent Creb family members. Thus, Foxo3a not only is an effector of PKB but also integrates distinct signals to regulate gene expression in erythropoiesis. Copyright </description>
    </item> <item>
      <title>The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13817/</link>
      <pubDate>2005-06-01T00:00:00Z</pubDate>
      <description>Development of red blood cells requires the correct regulation of cellular processes including changes in cell morphology, globin expression and heme synthesis. Transcription factors such as erythroid Kruppel-like factor EKLF (Klf1) play a critical role in erythropoiesis. Mice lacking EKLF die around embryonic day 14 because of defective definitive erythropoiesis, partly caused by a deficit in beta-globin expression. To identify additional target genes, we analyzed the phenotype and gene expression profiles of wild-type and EKLF null primary erythroid progenitors that were differentiated synchronously in vitro. We show that EKLF is dispensable for expansion of erythroid progenitors, but required for the last steps of erythroid differentiation. We identify EKLF-dependent genes involved in hemoglobin metabolism and membrane stability. Strikingly, expression of these genes is also EKLF-dependent in primitive, yolk sac-derived, blood cells. Consistent with lack of upregulation of these genes we find previously undetected morphological abnormalities in EKLF-null primitive cells. Our data provide an explanation for the hitherto unexplained severity of the EKLF null phenotype in erythropoiesis.</description>
    </item> <item>
      <title>FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1 (Article)</title>
      <link>http://repub.eur.nl/res/pub/8361/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>Erythropoiesis requires tight control of expansion, maturation, and
      survival of erythroid progenitors. Because activation of
      phosphatidylinositol-3-kinase (PI3K) is required for erythropoietin/stem
      cell factor-induced expansion of erythroid progenitors, we examined the
      role of the PI3K-controlled Forkhead box, class O (FoxO) subfamily of
      Forkhead transcription factors. FoxO3a expression and nuclear accumulation
      increased during erythroid differentiation, whereas untimely induction of
      FoxO3a activity accelerated differentiation of erythroid progenitors to
      erythrocytes. We identified B cell translocation gene 1
      (BTG1)/antiproliferative protein 2 as a FoxO3a target gene in erythroid
      progenitors. Promoter studies indicated BTG1 as a direct target of FoxO3a.
      Expression of BTG1 in primary mouse bone marrow cells blocked the
      outgrowth of erythroid colonies, which required a domain of BTG1 that
      binds protein arginine methyl transferase 1. During erythroid
      differentiation, increased arginine methylation coincided with BTG1
      expression. Concordantly, inhibition of methyl transferase activity
      blocked erythroid maturation without affecting expansion of progenitor
      cells. We propose FoxO3a-controlled expression of BTG1 and subsequent
      regulation of protein arginine methyl transferase activity as a novel
      mechanism controlling erythroid expansion and differentiation.</description>
    </item> <item>
      <title>The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro (Article)</title>
      <link>http://repub.eur.nl/res/pub/9135/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Although erythropoietin (Epo) is essential for the production of mature
          red blood cells, the cooperation with other factors is required for a
          proper balance between progenitor proliferation and differentiation. In
          avian erythroid progenitors, steroid hormones cooperate with tyrosine
          kinase receptors to induce renewal of erythroid progenitors. We examined
          the role of corticosteroids in the in vitro expansion of primary human
          erythroid cells in liquid cultures and colony assays. Dexamethasone (Dex),
          a synthetic glucocorticoid hormone, cooperated with Epo and stem cell
          factor to induce erythroid progenitors to undergo 15 to 22 cell divisions,
          corresponding to a 10(5)- to 10(6)-fold amplification of erythroid cells.
          Dex acted directly on erythroid progenitors and maintained the
          colony-forming capacity of the progenitor cells expanded in liquid
          cultures. The hormone delayed terminal differentiation into erythrocytes,
          which was assayed by morphology, hemoglobin accumulation, and the
          expression of genes characteristic for immature cells. Sustained
          proliferation of erythroid progenitors could be induced equally well from
          purified erythroid burst-forming units (BFU-E), from CD34(+) blast cells,
          and from bone marrow depleted from CD34(+) cells.</description>
    </item>
  </channel>
</rss>